Bermudez, Irish Grace A.
HRN: 21-00-97 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/03/2022
CEFUROXIME 750MG (VIAL)
06/03/2022
06/04/2022
IV
1.5g LD
1 Dose Prior OR
For Repeat Cs; G3p2 2002 S/P CSX 2 (2008, 2013)
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes